Skip to main content
Top
Published in: Aesthetic Plastic Surgery 1/2022

01-02-2022 | Mastectomy | Original Article

Evaluation of the Number of Follow-up Surgical Procedures and Time Required for Delayed Breast Reconstruction by Clinical Risk Factors, Type of Oncological Therapy, and Reconstruction Approach

Authors: Pavla Ticha, Meagan Wu, Ondrej Mestak, Andrej Sukop

Published in: Aesthetic Plastic Surgery | Issue 1/2022

Login to get access

Abstract

Background

Breast reconstructive surgery is often a multistage process. The aim was to understand which factors might increase the number of follow-up surgeries and the length of time required to complete the reconstruction process.

Methods

A cross-sectional analysis was performed. Clinical data of 110 patients who underwent delayed postmastectomy breast reconstruction with a 5-year examination period were reviewed retrospectively. Impact of clinical risk factors, oncological therapy, and reconstruction approach on the number of surgeries and the length of required time was analyzed. Mann–Whitney U test and Kruskal–Wallis rank sum test were used.

Results

In patients undergoing perioperative hormone therapy, an average of 2.9 surgeries and length of 20.2 months were required compared to 2.3 surgeries and 14.0 months in patients without hormone therapy (P = 0.003; P = 0.005). Previous abdominal surgery was associated with an increased number of breast reconstruction stages of 3.1 per patient (P = 0.056) and a longer reconstruction time of 23.0 months (P = 0.050). Patients undergoing nipple reconstruction or implant revision required an increased number of surgeries (P < 0.001; P = 0.012) and a longer reconstruction time (P = 0.002; P < 0.001). Contralateral breast surgery and flap revision were associated only with an increased number of surgeries (P < 0.001; P < 0.001).

Conclusion

Perioperative hormone therapy was associated with a significantly higher number of surgeries and duration of time required to complete the reconstruction process. The highest increase in the number of surgeries was in patients with flap revision including anastomosis revision and necrectomy.

Level of Evidence IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Appendix
Available only for authorised users
Literature
1.
go back to reference Spear SL, Mardini S, Ganz JC (2003) Resource cost comparison of implant-based breast reconstruction versus TRAM flap breast reconstruction. Plast Reconstr Surg 112:101–105CrossRef Spear SL, Mardini S, Ganz JC (2003) Resource cost comparison of implant-based breast reconstruction versus TRAM flap breast reconstruction. Plast Reconstr Surg 112:101–105CrossRef
2.
go back to reference Wolf L (2004) The information needs of women who have undergone breast reconstruction. Part II: Information giving and content of information. Eur J Oncol Nurs 8:315–324CrossRef Wolf L (2004) The information needs of women who have undergone breast reconstruction. Part II: Information giving and content of information. Eur J Oncol Nurs 8:315–324CrossRef
3.
go back to reference Bennett KG, Qi J, Kim HM, Hamill JB, Pusic AL, Wilkins EG (2018) Comparison of 2-Year Complication Rates Among Common Techniques for Postmastectomy Breast Reconstruction. JAMA Surg 153:901–908CrossRef Bennett KG, Qi J, Kim HM, Hamill JB, Pusic AL, Wilkins EG (2018) Comparison of 2-Year Complication Rates Among Common Techniques for Postmastectomy Breast Reconstruction. JAMA Surg 153:901–908CrossRef
4.
go back to reference Spector DJ, Mayer DK, Knafl K, Pusic A (2011) Women’s recovery experiences after breast cancer reconstruction surgery. J Psychosoc Oncol 29:664–676CrossRef Spector DJ, Mayer DK, Knafl K, Pusic A (2011) Women’s recovery experiences after breast cancer reconstruction surgery. J Psychosoc Oncol 29:664–676CrossRef
5.
go back to reference Eom JS, Kobayashi MR, Paydar K, Wirth GA, Evans GR (2014) The number of operations required for completing breast reconstruction. Plast Reconstr Surg Glob Open 2: e242 Eom JS, Kobayashi MR, Paydar K, Wirth GA, Evans GR (2014) The number of operations required for completing breast reconstruction. Plast Reconstr Surg Glob Open 2: e242
6.
go back to reference Herly M, Ørholt M, Larsen A, Pipper CB, Bredgaard R, Gramkow CS, Katz AJ, Drzewiecki KT, Vester-Glowinski PV (2018) Efficacy of breast reconstruction with fat grafting: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 71:1740–1750CrossRef Herly M, Ørholt M, Larsen A, Pipper CB, Bredgaard R, Gramkow CS, Katz AJ, Drzewiecki KT, Vester-Glowinski PV (2018) Efficacy of breast reconstruction with fat grafting: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 71:1740–1750CrossRef
7.
go back to reference Losken A, Carlson GW, Schoemann MB, Jones GE, Culbertson JH, Hester TR (2004) Factors that influence the completion of breast reconstruction. Ann Plast Surg 52:258–262CrossRef Losken A, Carlson GW, Schoemann MB, Jones GE, Culbertson JH, Hester TR (2004) Factors that influence the completion of breast reconstruction. Ann Plast Surg 52:258–262CrossRef
8.
go back to reference Nelson JA, Voineskos SH, Qi J, Kim HM, Hamill JB, Wilkins EG, Pusic AL (2019) Elective Revisions after Breast Reconstruction: Results from the Mastectomy Reconstruction Outcomes Consortium. Plast Reconstr Surg 144:1280–1290CrossRef Nelson JA, Voineskos SH, Qi J, Kim HM, Hamill JB, Wilkins EG, Pusic AL (2019) Elective Revisions after Breast Reconstruction: Results from the Mastectomy Reconstruction Outcomes Consortium. Plast Reconstr Surg 144:1280–1290CrossRef
9.
go back to reference Ainslie NB, Ojeda-Fournier H (1996) Creating a realistic breast: the nipple-areola reconstruction. Plast Surg Nurs 16:156–165CrossRef Ainslie NB, Ojeda-Fournier H (1996) Creating a realistic breast: the nipple-areola reconstruction. Plast Surg Nurs 16:156–165CrossRef
10.
go back to reference Wukich DK (2015) Diabetes and its negative impact on outcomes in orthopaedic surgery. World J Orthop 6:331–339CrossRef Wukich DK (2015) Diabetes and its negative impact on outcomes in orthopaedic surgery. World J Orthop 6:331–339CrossRef
11.
go back to reference Rifkin WJ, Kantar RS, Cammarata MJ, Wilson SC, Diaz-Siso JR, Golas AR, Levine JP, Ceradini DJ (2019) Impact of Diabetes on 30-Day Complications in Mastectomy and Implant-Based Breast Reconstruction. J Surg Res 235:148–159CrossRef Rifkin WJ, Kantar RS, Cammarata MJ, Wilson SC, Diaz-Siso JR, Golas AR, Levine JP, Ceradini DJ (2019) Impact of Diabetes on 30-Day Complications in Mastectomy and Implant-Based Breast Reconstruction. J Surg Res 235:148–159CrossRef
12.
go back to reference Sultan SM, Seth AK, Lamelas AM, Greenspun DT, Erhard HA (2020) Bipedicle-Conjoined Deep Inferior Epigastric Perforator Flaps for Unilateral Breast Reconstruction in Overweight and Obese Patients: Do the Benefits Outweigh the Risks? J Reconstr Microsurg 36:346–352CrossRef Sultan SM, Seth AK, Lamelas AM, Greenspun DT, Erhard HA (2020) Bipedicle-Conjoined Deep Inferior Epigastric Perforator Flaps for Unilateral Breast Reconstruction in Overweight and Obese Patients: Do the Benefits Outweigh the Risks? J Reconstr Microsurg 36:346–352CrossRef
13.
14.
go back to reference Hwang K, Son JS, Ryu WK (2018) Smoking and Flap Survival. Plast Surg (Oakv) 26:280–285CrossRef Hwang K, Son JS, Ryu WK (2018) Smoking and Flap Survival. Plast Surg (Oakv) 26:280–285CrossRef
15.
go back to reference Dancey A, Nassimizadeh A, Levick P (2012) Capsular contracture - What are the risk factors? A 14 year series of 1400 consecutive augmentations. J Plast Reconstr Aesthet Surg 65:213–218CrossRef Dancey A, Nassimizadeh A, Levick P (2012) Capsular contracture - What are the risk factors? A 14 year series of 1400 consecutive augmentations. J Plast Reconstr Aesthet Surg 65:213–218CrossRef
16.
go back to reference Adachi Y, Okumura S, Sawaki M et al (2020) Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction. Breast Cancer 27:716–723CrossRef Adachi Y, Okumura S, Sawaki M et al (2020) Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction. Breast Cancer 27:716–723CrossRef
17.
go back to reference Banuelos J, Sabbagh MD, Roh SG, Nguyen MT, Lemaine V, Tran NV, Jacobson SR, Boughey JC, Jakub JW, Hieken TJ, Degnim AC, Mandrekar J, Berbari E, Sharaf B (2019) Infections following Immediate Implant-Based Breast Reconstruction: A Case-Control Study over 11 Years. Plast Reconstr Surg 144:1270–1277CrossRef Banuelos J, Sabbagh MD, Roh SG, Nguyen MT, Lemaine V, Tran NV, Jacobson SR, Boughey JC, Jakub JW, Hieken TJ, Degnim AC, Mandrekar J, Berbari E, Sharaf B (2019) Infections following Immediate Implant-Based Breast Reconstruction: A Case-Control Study over 11 Years. Plast Reconstr Surg 144:1270–1277CrossRef
18.
go back to reference Madsen RJ, Esmonde NO, Ramsey KL, Hansen JE (2016) Axillary lymph node dissection is a risk factor for major complications after immediate breast reconstruction. Ann Plast Surg 77:513–516CrossRef Madsen RJ, Esmonde NO, Ramsey KL, Hansen JE (2016) Axillary lymph node dissection is a risk factor for major complications after immediate breast reconstruction. Ann Plast Surg 77:513–516CrossRef
19.
go back to reference Dormand EL, Banwell PE, Goodacre TE (2005) Radiotherapy and wound healing. Int Wound J 2:112–127CrossRef Dormand EL, Banwell PE, Goodacre TE (2005) Radiotherapy and wound healing. Int Wound J 2:112–127CrossRef
20.
go back to reference Mehanni SS, Ibrahim NF, Hassan AR, Rashed LA (2013) New approach of bone marrow-derived mesenchymal stem cells and human amniotic epithelial cells applications in accelerating wound healing of irradiated albino rats. Int J Stem Cells 6:45–54CrossRef Mehanni SS, Ibrahim NF, Hassan AR, Rashed LA (2013) New approach of bone marrow-derived mesenchymal stem cells and human amniotic epithelial cells applications in accelerating wound healing of irradiated albino rats. Int J Stem Cells 6:45–54CrossRef
21.
go back to reference Veronesi P, Ballardini B, De Lorenzi F, Magnoni F, Lissidini G, Caldarella P, Galimberti V (2011) Immediate breast reconstruction after mastectomy. Breast 20(Suppl 3):S104-107CrossRef Veronesi P, Ballardini B, De Lorenzi F, Magnoni F, Lissidini G, Caldarella P, Galimberti V (2011) Immediate breast reconstruction after mastectomy. Breast 20(Suppl 3):S104-107CrossRef
22.
go back to reference Williams N, Harris LN (2014) The renaissance of endocrine therapy in breast cancer. Curr Opin Obstet Gynecol 26:41–47CrossRef Williams N, Harris LN (2014) The renaissance of endocrine therapy in breast cancer. Curr Opin Obstet Gynecol 26:41–47CrossRef
23.
go back to reference Shah MG, Maibach HI (2001) Estrogen and skin. Am J Clin Dermatol 2:143–150CrossRef Shah MG, Maibach HI (2001) Estrogen and skin. Am J Clin Dermatol 2:143–150CrossRef
24.
go back to reference Ashcroft GS, Dodsworth J, van Boxtel E, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW (1997) Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 3:1209–1215CrossRef Ashcroft GS, Dodsworth J, van Boxtel E, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW (1997) Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 3:1209–1215CrossRef
25.
go back to reference Billon R, Bosc R, Belkacemi Y, Assaf E, SidAhmed-Mezi M, Hersant B, Meningaud JP (2017) Impact of adjuvant anti-estrogen therapies (tamoxifen and aromatase inhibitors) on perioperative outcomes of breast reconstruction. J Plast Reconstr Aesthet Surg 70:1495–1504CrossRef Billon R, Bosc R, Belkacemi Y, Assaf E, SidAhmed-Mezi M, Hersant B, Meningaud JP (2017) Impact of adjuvant anti-estrogen therapies (tamoxifen and aromatase inhibitors) on perioperative outcomes of breast reconstruction. J Plast Reconstr Aesthet Surg 70:1495–1504CrossRef
26.
go back to reference Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R. Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381:805–816 Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R. Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381:805–816
27.
go back to reference Prandoni P (2009) Venous and arterial thrombosis: two aspects of the same disease? Clin Epidemiol 1:1–6CrossRef Prandoni P (2009) Venous and arterial thrombosis: two aspects of the same disease? Clin Epidemiol 1:1–6CrossRef
28.
go back to reference Kelley BP, Valero V, Yi M, Kronowitz SJ (2012) Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction. Plast Reconstr Surg 129:305–314CrossRef Kelley BP, Valero V, Yi M, Kronowitz SJ (2012) Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction. Plast Reconstr Surg 129:305–314CrossRef
29.
go back to reference Mirzabeigi MN, Nelson JA, Fischer JP, Kovach SJ, Serletti JM, Wu LC, Kanchwala S (2015) Tamoxifen (selective estrogen-receptor modulators) and aromatase inhibitors as potential perioperative thrombotic risk factors in free flap breast reconstruction. Plast Reconstr Surg 135:670–679CrossRef Mirzabeigi MN, Nelson JA, Fischer JP, Kovach SJ, Serletti JM, Wu LC, Kanchwala S (2015) Tamoxifen (selective estrogen-receptor modulators) and aromatase inhibitors as potential perioperative thrombotic risk factors in free flap breast reconstruction. Plast Reconstr Surg 135:670–679CrossRef
30.
go back to reference Duggal CS, Grudziak J, Metcalfe DB, Carlson GW, Losken A (2013) The effects of breast size in unilateral postmastectomy breast reconstruction. Ann Plast Surg 70:506–512CrossRef Duggal CS, Grudziak J, Metcalfe DB, Carlson GW, Losken A (2013) The effects of breast size in unilateral postmastectomy breast reconstruction. Ann Plast Surg 70:506–512CrossRef
31.
go back to reference Pusic AL, Matros E, Fine N, Buchel E, Gordillo GM, Hamill JB, Kim HM, Qi J, Albornoz C, Klassen AF, Wilkins EG (2017) Patient-reported outcomes 1 year after immediate breast reconstruction: results of the mastectomy reconstruction outcomes consortium study. J Clin Oncol 35:2499–2506CrossRef Pusic AL, Matros E, Fine N, Buchel E, Gordillo GM, Hamill JB, Kim HM, Qi J, Albornoz C, Klassen AF, Wilkins EG (2017) Patient-reported outcomes 1 year after immediate breast reconstruction: results of the mastectomy reconstruction outcomes consortium study. J Clin Oncol 35:2499–2506CrossRef
32.
go back to reference Momeni A, Ghaly M, Gupta D, Gurtner G, Kahn DM, Karanas YL, Lee GK (2013) Nipple reconstruction after implant-based breast reconstruction: a “matched-pair” outcome analysis focusing on the effects of radiotherapy. J Plast Reconstr Aesthet Surg 66:1202–1205CrossRef Momeni A, Ghaly M, Gupta D, Gurtner G, Kahn DM, Karanas YL, Lee GK (2013) Nipple reconstruction after implant-based breast reconstruction: a “matched-pair” outcome analysis focusing on the effects of radiotherapy. J Plast Reconstr Aesthet Surg 66:1202–1205CrossRef
33.
go back to reference Toyserkani NM, Jørgensen MG, Tabatabaeifar S, Damsgaard T, Sørensen JA (2020) Autologous versus implant-based breast reconstruction: a systematic review and meta-analysis of Breast-Q patient-reported outcomes. J Plast Reconstr Aesthet Surg 73:278–285CrossRef Toyserkani NM, Jørgensen MG, Tabatabaeifar S, Damsgaard T, Sørensen JA (2020) Autologous versus implant-based breast reconstruction: a systematic review and meta-analysis of Breast-Q patient-reported outcomes. J Plast Reconstr Aesthet Surg 73:278–285CrossRef
34.
go back to reference Levine SM, Lester ME, Fontenot B, Allen RJ Sr (2011) Perforator flap breast reconstruction after unsatisfactory implant reconstruction. Ann Plast Surg 66:513–517CrossRef Levine SM, Lester ME, Fontenot B, Allen RJ Sr (2011) Perforator flap breast reconstruction after unsatisfactory implant reconstruction. Ann Plast Surg 66:513–517CrossRef
Metadata
Title
Evaluation of the Number of Follow-up Surgical Procedures and Time Required for Delayed Breast Reconstruction by Clinical Risk Factors, Type of Oncological Therapy, and Reconstruction Approach
Authors
Pavla Ticha
Meagan Wu
Ondrej Mestak
Andrej Sukop
Publication date
01-02-2022
Publisher
Springer US
Published in
Aesthetic Plastic Surgery / Issue 1/2022
Print ISSN: 0364-216X
Electronic ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-021-02580-1

Other articles of this Issue 1/2022

Aesthetic Plastic Surgery 1/2022 Go to the issue